{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:02:06Z","timestamp":1791428526436,"version":"4.3.3"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["KR 4689\/3-1"],"award-info":[{"award-number":["KR 4689\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Torsten S\u00f6derberg Foundation, Stockholm, Sweden"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["#2018-02532"],"award-info":[{"award-number":["#2018-02532"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["#681712"],"award-info":[{"award-number":["#681712"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish State Support for Clinical Research","award":["#ALFGBG-720931"],"award-info":[{"award-number":["#ALFGBG-720931"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jad.2019.04.080","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T23:20:01Z","timestamp":1555543201000},"page":"449-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy\u2014A pilot study"],"prefix":"10.1016","volume":"253","author":[{"given":"Laura","family":"Kranaster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Sartorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jad.2019.04.080_bib0001","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-6147(99)01309-7","article-title":"Neurotrophins and depression","volume":"20","author":"Altar","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.jad.2019.04.080_bib0002","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1523\/JNEUROSCI.5377-03.2004","article-title":"Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways","volume":"24","author":"Altar","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jad.2019.04.080_bib0003","series-title":"The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging (A Task Force Report of the American Psychiatric Association)","year":"2001"},{"key":"10.1016\/j.jad.2019.04.080_bib0004","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/cphy.c170015","article-title":"Physiological Role of Vascular Endothelial Growth Factors as Homeostatic Regulators","volume":"8","author":"Bates","year":"2018","journal-title":"Compr. Physiol."},{"issue":"3","key":"10.1016\/j.jad.2019.04.080_bib0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00406-014-0543-3","article-title":"Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients","volume":"265","author":"Bumb","year":"2015","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2019.04.080_bib0006","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.psyneuen.2015.07.002","article-title":"Peripheral vascular endothelial growth factor as a novel depression biomarker: a meta-analysis","volume":"62","author":"Carvalho","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"10.1016\/j.jad.2019.04.080_bib0007","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jpsychires.2013.04.008","article-title":"VEGF and depression: a comprehensive assessment of clinical data","volume":"47","author":"Clark-Raymond","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"07","key":"10.1016\/j.jad.2019.04.080_bib0008","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0035-1555849","article-title":"Antidepressant treatment with venlafaxine and mirtazapine: no effect on serum concentration of vascular endothelial growth factor (VEGF)","volume":"48","author":"Deuschle","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2019.04.080_bib0009","article-title":"Neurotrophic and antidepressant actions of brain-derived neurotrophic factor require vascular endothelial growth factor","author":"Deyama","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.04.080_bib0010","unstructured":"Duffy, A., Bouchier-Hayes, D., Harmey, J., 2000\u20132013. Vascular endothelial growth factor (VEGF) and its role in non-endothelial cells: autocrine signalling by VEGF. Landes Bioscience, Madame Curie Bioscience Database [Internet], Austin (TX)."},{"issue":"7","key":"10.1016\/j.jad.2019.04.080_bib0011","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archpsyc.1997.01830190015002","article-title":"A molecular and cellular theory of depression","volume":"54","author":"Duman","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2019.04.080_bib0012","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00018-012-1020-7","article-title":"Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes","volume":"70","author":"Duric","year":"2013","journal-title":"Cell Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.jad.2019.04.080_bib0013","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2174\/1567205014666170329113007","article-title":"Is VEGF a key target of cotinine and other potential therapies against alzheimer disease?","volume":"14","author":"Echeverria","year":"2017","journal-title":"Curr. Alzheimer Res."},{"issue":"4","key":"10.1016\/j.jad.2019.04.080_bib0014","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/syn.21518","article-title":"Electroconvulsive seizures stimulate the vegf pathway via mTORC1","volume":"66","author":"Elfving","year":"2012","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.jad.2019.04.080_bib0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bbr.2011.04.022","article-title":"Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression","volume":"227","author":"Fournier","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.jad.2019.04.080_bib0016","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jad.2019.04.080_bib0017","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ddmec.2004.10.007","article-title":"Mechanisms of depression: the role of neurogenesis","volume":"1","author":"Henn","year":"2004","journal-title":"Drug Discovery Today Dis. Mech. I"},{"issue":"3","key":"10.1016\/j.jad.2019.04.080_bib0018","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00406-013-0420-5","article-title":"Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study","volume":"264","author":"Hoyer","year":"2014","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.jad.2019.04.080_bib0019","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.euroneuro.2017.12.012","article-title":"Electroconvulsive therapy enhances the anti-ageing hormone Klotho in the cerebrospinal fluid of geriatric patients with major depression","volume":"28","author":"Hoyer","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.jad.2019.04.080_bib0020","doi-asserted-by":"crossref","first-page":"e69869","DOI":"10.1371\/journal.pone.0069869","article-title":"Electroconvulsive therapy induces neurogenesis in frontal rat brain areas","volume":"8","author":"Inta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2019.04.080_bib0021","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1038\/tp.2012.123","article-title":"Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters","volume":"2","author":"Isung","year":"2012","journal-title":"Transl. Psychiatry"},{"issue":"12","key":"10.1016\/j.jad.2019.04.080_bib0022","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.euroneuro.2016.11.004","article-title":"Electroconvulsive therapy selectively enhances amyloid beta 1-42 in the cerebrospinal fluid of patients with major depression: a prospective pilot study","volume":"26","author":"Kranaster","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"8","key":"10.1016\/j.jad.2019.04.080_bib0023","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00406-017-0789-7","article-title":"Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study","volume":"267","author":"Kranaster","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.jad.2019.04.080_bib0024","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/15622975.2017.1355473","article-title":"Antidepressant efficacy of electroconvulsive therapy is associated with a reduction of the innate cellular immune activity in the cerebrospinal fluid in patients with depression","volume":"19","author":"Kranaster","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2019.04.080_bib0025","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00406-011-0205-7","article-title":"Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study","volume":"261","author":"Kranaster","year":"2011","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.jad.2019.04.080_bib0026","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrneurol.2016.88","article-title":"Vascular endothelial growth factor: a neurovascular target in neurological diseases","volume":"12","author":"Lange","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.jad.2019.04.080_bib0027","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00018-013-1280-x","article-title":"Delineating multiple functions of VEGF-A in the adult brain","volume":"70","author":"Licht","year":"2013","journal-title":"Cell Mol. Life Sci."},{"issue":"39","key":"10.1016\/j.jad.2019.04.080_bib0028","doi-asserted-by":"crossref","first-page":"8889","DOI":"10.1523\/JNEUROSCI.2577-05.2005","article-title":"Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures","volume":"25","author":"McCloskey","year":"2005","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.jad.2019.04.080_bib0029","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/acps.12187","article-title":"Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy","volume":"129","author":"Minelli","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.jad.2019.04.080_bib0030","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.pnpbp.2011.04.013","article-title":"Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients","volume":"35","author":"Minelli","year":"2011","journal-title":"Progress Neuro-psychopharmacol. Biol. Psychiatry"},{"issue":"34","key":"10.1016\/j.jad.2019.04.080_bib0031","doi-asserted-by":"crossref","first-page":"10841","DOI":"10.1523\/JNEUROSCI.23-34-10841.2003","article-title":"Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors","volume":"23","author":"Newton","year":"2003","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.jad.2019.04.080_bib0032","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00018-013-1281-9","article-title":"Vascular growth factors in neuropsychiatry","volume":"70","author":"Newton","year":"2013","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.jad.2019.04.080_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2011.05.005","article-title":"Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action","volume":"46","author":"Nowacka","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.jad.2019.04.080_bib0034","first-page":"255","article-title":"Handling results below the level of detection","volume":"54","author":"Ogden","year":"2010","journal-title":"Ann. Occup. Hyg."},{"issue":"5","key":"10.1016\/j.jad.2019.04.080_bib0035","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1161\/STROKEAHA.117.020557","article-title":"Growth hormone improves cognitive function after experimental stroke","volume":"49","author":"Ong","year":"2018","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.jad.2019.04.080_bib0036","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.npp.1301574","article-title":"Stress, depression, and neuroplasticity: a convergence of mechanisms","volume":"33","author":"Pittenger","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2019.04.080_bib0037","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jad.2014.11.044","article-title":"BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis","volume":"174","author":"Polyakova","year":"2015","journal-title":"Journal of Affect. Disord."},{"key":"10.1016\/j.jad.2019.04.080_bib0038","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpsychires.2016.08.004","article-title":"Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: a meta-analysis study","volume":"83","author":"Rocha","year":"2016","journal-title":"J. Psychiatr Res."},{"key":"10.1016\/j.jad.2019.04.080_bib0039","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/723915","article-title":"Hippocampal neurogenesis and antidepressive therapy: shocking relations","volume":"2014","author":"Rotheneichner","year":"2014","journal-title":"Neural. Plast."},{"key":"10.1016\/j.jad.2019.04.080_bib0040","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1152\/physrev.00031.2008","article-title":"Role and therapeutic potential of VEGF in the nervous system","volume":"89","author":"Ruiz de Almodovar","year":"2009","journal-title":"Physiol. Rev."},{"issue":"8","key":"10.1016\/j.jad.2019.04.080_bib0041","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00406-018-0919-x","article-title":"Vascular endothelial growth factor plasma levels in depression and following electroconvulsive therapy","volume":"268","author":"Ryan","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2019.04.080_bib0042","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.euroneuro.2015.12.036","article-title":"Electroconvulsive therapy increases temporal gray matter volume and cortical thickness","volume":"26","author":"Sartorius","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.jad.2019.04.080_bib0043","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.brs.2018.11.017","article-title":"Electroconvulsive therapy induced gray matter increase is not necessarily correlated with clinical data in depressed patients","volume":"12","author":"Sartorius","year":"2019","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jad.2019.04.080_bib0044","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0029-1224162","article-title":"Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats","volume":"42","author":"Sartorius","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2019.04.080_bib0045","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1248\/bpb.34.939","article-title":"Exploration of new molecular mechanisms for antidepressant actions of electroconvulsive seizure","volume":"34","author":"Segi-Nishida","year":"2011","journal-title":"Biol. Pharmaceutical Bull."},{"key":"10.1016\/j.jad.2019.04.080_bib0046","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jad.2016.02.067","article-title":"Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: a comprehensive review of human studies","volume":"197","author":"Sharma","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.04.080_bib0047","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/glia.20187","article-title":"Stem\/progenitor cell proliferation factors FGF-2, IGF-1, and VEGF exhibit early decline during the course of aging in the hippocampus: role of astrocytes","volume":"51","author":"Shetty","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.jad.2019.04.080_bib0048","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.euroneuro.2012.10.012","article-title":"Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients","volume":"23","author":"Stelzhammer","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2019.04.080_bib0049","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/CS20040370","article-title":"The vascular endothelial growth factor (VEGF)\/VEGF receptor system and its role under physiological and pathological conditions","volume":"109","author":"Takahashi","year":"2005","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.jad.2019.04.080_bib0050","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1470-2045(01)00556-3","article-title":"Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications","volume":"2","author":"Toi","year":"2001","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jad.2019.04.080_bib0051","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coph.2007.10.013","article-title":"VEGF as a potential target for therapeutic intervention in depression","volume":"8","author":"Warner-Schmidt","year":"2008","journal-title":"Curr. Opin. Pharmacol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719303398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719303398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T19:41:52Z","timestamp":1572982912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032719303398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":51,"alternative-id":["S0165032719303398"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2019.04.080","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy\u2014A pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2019.04.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}